World Health Day 2019 Celebrates Health As A Human Right 08/04/2019 Divya Schlesinger Drummers, dancers, and speakers blasting Lady Gaga for a crowd of five hundred people linking hands and doing the wave is not the image typically conjured up when one hears of a World Health Organization event. A crowd gathered beneath a small stage decorated with slogans championing universal health coverage. Despite the morning’s chill lingering […] Continue reading -> Global Life Expectancy Improved, Women Outlive Men, But Gaps Persist Based On Income 04/04/2019 David Branigan Global life expectancy at birth has increased from 65.5 years in 2000 to 72 years in 2016, a new World Health Organization report has found. But despite this overall improvement, significant disparities persist: life expectancy in low-income countries was 18.1 years lower than in high-income countries in 2016. Image Credits: WHO/J. Holmes. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
Global Life Expectancy Improved, Women Outlive Men, But Gaps Persist Based On Income 04/04/2019 David Branigan Global life expectancy at birth has increased from 65.5 years in 2000 to 72 years in 2016, a new World Health Organization report has found. But despite this overall improvement, significant disparities persist: life expectancy in low-income countries was 18.1 years lower than in high-income countries in 2016. Image Credits: WHO/J. Holmes. Continue reading -> Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
Africa Loses $US 2.4 Trillion Annually To Diseases – WHO Study Calls For Health Investment 01/04/2019 David Branigan In 2015, Sub-Saharan Africans lost 630 million “healthy life years” as a result of sickness and disease, amounting to an estimated loss of $US 2.4 trillion for the region, a new study finds. These economic losses, it says, emphasise the need for increased investment in health financing in Africa to achieve universal health coverage (UHC) […] Continue reading -> WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
WHO Essential Medicines Review : Cancer Drugs, Insulin Analogues Draw Controversy 01/04/2019 Elaine Ruth Fletcher Expanding access to costly cancer treatments and the high price of new generation insulin formulas were among the controversial topics of debate today as the WHO Expert Committee on the Selection and Use of Essential Medicines convened for its biennial update of the list of over 400 drugs deemed most essential for treating public health needs […] Continue reading -> The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
The Economist AMR Summit: “Broadening” Stakeholders To Strengthen Call To Action 27/03/2019 David Branigan A “broader” call to action engaging a “wider universe of advocates,” is needed to more effectively tackle antimicrobial resistance (AMR) – including everyone from financial investors to environmental groups. This was the message emerging out of a global meeting on the issue yesterday in London. Image Credits: The Economist. Continue reading -> Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
Access To Essential Medicines – Charles Gore Speaks About MPP’s Expanding Role 25/03/2019 William New Charles Gore took over the role of Executive Director at the Medicines Patent Pool in July 2018, just after its board decided to greatly expand its mandate into essential medicines. Nine months into his term, IP-Watch’s William New talked with him about his role and how the expansion is going. Continue reading -> UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
UNAIDS Reports Mixed Progress Towards Reaching The 2020 Target Of Reducing TB Deaths Among People Living With HIV By 75% 22/03/2019 Editorial team [Press Release by UNAIDS] Five countries met the target three years ahead of the 2020 deadline and 18 more are on track; however, most countries are lagging behind and risk missing the target completely. UNAIDS urges countries to step up action. GENEVA, 22 March 2019—Ahead of World Tuberculosis Day, on 24 March 2019, UNAIDS […] Continue reading -> New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
New WHO Recommendations To Accelerate Progress On TB 20/03/2019 Editorial team [WHO Press Release] WHO has issued new guidance to improve treatment of multidrug resistant TB (MDR-TB). WHO is recommending shifting to fully oral regimens to treat people with MDR-TB. This new treatment course is more effective and is less likely to provoke adverse side effects. WHO recommends backing up treatment with active monitoring of drug safety and […] Continue reading -> TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
TB Remains A Major Public Health Problem In Europe, Report Finds 19/03/2019 David Branigan A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading -> UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts
UNAIDS Urges Worldwide Reform Of Drug Policies – Links To HIV Prevention, Human Rights 14/03/2019 Elaine Ruth Fletcher UNAIDS urged UN member states convening today in Vienna for the UN Commission on Narcotic Drugs to enact sweeping reforms of policies towards injecting drug users, most of whom lack critical access to basic “harm reduction” services that could prevent them from becoming infected with HIV. Continue reading -> Posts navigation Older postsNewer posts